Adequate vitamin K levels are needed to activate osteocalcin, leading it to be a key research area for bone health potential.
Research last year suggested supplementation of 180 micrograms of the vitamin daily reduced bone loss and improved bone impact strength in postmenopausal women.
Whilst these results were positive, there have been some questions about how the vitamin interacts with calcium, magnesium and vitamin D when combined in supplement tablets.
Distributed XSTO Solutions said: “What we’ve just recently concluded is that some forms of calcium and some forms of magnesium have been breaking down the vitamin K2. This is not just our K2, it was true of other forms we’ve tested […] We think what the calcium and magnesium are doing is physically breaking the chain of the molecule.”